Xiaoqing Liu
8 Dongda Street
Beijing, 100071, China
Beijing, 100071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Radiomic-signature changes after early treatment improve the prediction of progression-free survival in patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.
Journal: Acta radiologica (Stockholm, Sweden : 1987)
Published: August 16, 2022
Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety From a Phase 2 Study in People's Republic of China.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 16, 2021
Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 07, 2021
Icotinib versus chemotherapy as adjuvant treatment for stage II-IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: December 28, 2020
Genomic Profiles of a Patient of Pulmonary Hepatoid Adenocarcinoma With High AFP Level: A Case Report.
Journal: Frontiers in oncology
Published: September 11, 2019
CDKN2A inhibits formation of homotypic cell-in-cell structures.
Journal: Oncogenesis
Published: December 11, 2017
Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: April 21, 2017
The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
Journal: Disease markers
Published: November 30, 2016
China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2016 version)
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: June 25, 2016
China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version).
Journal: Journal of thoracic disease
Published: December 02, 2015
Advances in diagnosis and treatment and whole process management of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: April 17, 2015
Last Updated: 09/26/2026